Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-09-30
1984-05-29
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546 63, A61K 31435, C07D47122
Patent
active
044514689
ABSTRACT:
Acidiferous salts of 17-.beta.-n-pentyl sparteine are crystallized out of a solution of 17-.beta.-n-pentyl sparteine and a dicarboxylic acid selected from the group consisting of tartaric acid, fumaric acid or mixtures thereof. The novel acidiferous pentyl sparteine salts are employed in pharmaceutical compositions for the treatment of cardiac disorders and in venous therapeutical applications, and process improved stability and pharmacological properties.
REFERENCES:
patent: 2946798 (1960-07-01), Rudner
patent: 3755333 (1973-08-01), Szantay et al.
patent: 4246713 (1981-01-01), Montzka et al.
Budden Renke
Buschmann Gerd
Hachmeister Bernd
Kuhl Ulrich
Milkowski Wolfgang
Coughlan, Jr. Paul M.
Kali-Chemie Pharma GmbH
Springer D. B.
LandOfFree
Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acidiferous 17-normal-pentyl sparteine tartaric and fumaric acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1397000